![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Advertisement
Persons > All
Find below all kinds of persons.Total search results: 16845 | Ordered by Organisation (Group) (descending)
1 2 3 ... 167 168 169 
  Person |
Position |
 Organisation (Group) |
Country |
|---|---|---|---|
| Veitschegger, Andrea (ÖGMBT 201105 Managing Director) | Managing Director | Österreichische Gesellschaft für Molekulare Biowissenschaften und Biotechnologie (ÖGMBT) | Austria |
| Van Bavel, Bert (Örbebro Univ 201212 Professor School of Science + Technology + MTM Research Center) | Professor | Örebro University (Örebro Universitet) | Sweden |
| Engel, Jürgen (Æterna Zentaris 200504) | Chief Operating Officer (COO) | Æterna Zentaris (Group) | Canada |
| Guenther, Eckhard (Aeterna Zentaris 201611 VP Alliance Management) | Business Development Manager / Strategy Manager | Æterna Zentaris (Group) | Germany |
| Kleemann, Axel (Asta Medica 1987–2000 before Degussa ua) | Board member | Æterna Zentaris (Group) | Germany |
| Teifel, Michael (Æterna Zentaris 201308 VP Preclinical Developm at Æterna Zentaris GmbH) | Research & Development Manager | Æterna Zentaris (Group) | Germany |
| Lippold, Marcus ([iito] Business Intelligence 2002–) | Company Founder | [iito] Business Intelligence | Germany |
| Debel, Karsten (Zytomed Systems 200912 Managing Director) | Managing Director | ZytoVision (Group) | Germany |
| Dittmer, Thomas (Zytomed Systems 200912 Managing Director) | Managing Director | ZytoVision (Group) | Germany |
| Hauke, Sven (ZytoVision GmbH 200405–200902– Managing Director + founder before Alcedo Biotech) | Managing Director | ZytoVision (Group) | Germany |
| Meiboom, Meike (ZytoVision 200705 Scientist) | n. a. | ZytoVision (Group) | Germany |
| Rogalla, Piere (ZytoVision GmbH 200405–200902– Managing Director + founder before Alcedo Biotech Managing Director) | Managing Director | ZytoVision (Group) | Germany |
| Weyrauch, Kerstin (Zytomed Systems 200912 Managing Director) | Managing Director | ZytoVision (Group) | Germany |
| Weilguni, Peter C. (Cytoprotec 201301 Managing Director) | Managing Director | Zytoprotec GmbH | Austria |
| Schier, Robert (Zürcher Kantonalbank 201909 Investment Director PE/V Health-Tech at Swisscanto Invest) | Investment Manager | Zürcher Kantonalbank (ZKB) | Switzerland |
| Schoch, Daniel (Zürcher Kantonalbank 201808 Head of Start-up FInance) | Investment Manager | Zürcher Kantonalbank (ZKB) | Switzerland |
| Poon, David (Zymeworks 201512 Senior Director External RnD + Alliances) | Business Development Manager / Strategy Manager | Zymeworks (Group) | Canada |
| Tehrani, Ali (Zymeworks 201510 CEO) | Chief Executive Officer (CEO) | Zymeworks (Group) | Canada |
| Fogh, Jens (Zymenex 200803 CEO) | Chief Executive Officer (CEO) | Zymenex (Group) | Denmark |
| Kofoed, Thomas (Alphalyse 201706 CEO) | Chief Executive Officer (CEO) | Zymenex (Group) | Denmark |
| Cuddon, Lorna (Zyme Communications 201007– Managing Director + Founder before College Hill Life Sciences) | Managing Director | Zyme Communications Ltd. | United Kingdom (GB) |
| Holland, Grace (Zyme Communications 202005) | Public Relations Manager / Investor Relations Manager | Zyme Communications Ltd. | United Kingdom (GB) |
| Jeffery, Lily (Zyme Communications 201708– Account Executive) | Public Relations Manager / Investor Relations Manager | Zyme Communications Ltd. | United Kingdom (GB) |
| Jeffery, Sarah (Zyme Communications 201504) | Public Relations Manager / Investor Relations Manager | Zyme Communications Ltd. | United Kingdom (GB) |
| Odgaard, Katie (Zyme Communications 201108 Senior Account Manager before College Hill Life Sciences) | Public Relations Manager / Investor Relations Manager | Zyme Communications Ltd. | United Kingdom (GB) |
| Pammenter-Fry, Ellen (Zyme Communications 201409– Account Executive) | Public Relations Manager / Investor Relations Manager | Zyme Communications Ltd. | United Kingdom (GB) |
| Rutter, Ben (Zyme Communications 202209) | Public Relations Manager / Investor Relations Manager | Zyme Communications Ltd. | United Kingdom (GB) |
| Spyrou, Maria (Zyme Communications 202305) | Public Relations Manager / Investor Relations Manager | Zyme Communications Ltd. | United Kingdom (GB) |
| Walters, Esmé (Zyme Communications 202301) | Public Relations Manager / Investor Relations Manager | Zyme Communications Ltd. | United Kingdom (GB) |
| Barker, Susan (ZyGEM 200801 VP Business Development before GE Healthcare) | Business Development Manager / Strategy Manager | ZyGEM (Group) | New Zealand |
| Schulz, Wolfgang (Zweckverband Landeswasserversorgung in Langenau 201504) | n. a. | Zweckverband Landeswasserversorung (Baden-Württemberg / Bayern) | Germany |
| Jünger, Katharina (TeleClinic 2015– Managing Director + Co-Founder) | Managing Director | Zur Rose Group (Group) | Germany |
| Lüthi, Lisa (Zur Rose Group 202007 Head of Group Communications) | Public Relations Manager / Investor Relations Manager | Zur Rose Group (Group) | Switzerland |
| Müller, Maximilian (TeleClinic 2015– Managing Director) | Managing Director | Zur Rose Group (Group) | Germany |
| Oberhänsli, Walter (Zur Rose Group 202007 CEO) | Chief Executive Officer (CEO) | Zur Rose Group (Group) | Switzerland |
| Ziwica, Marcel (Zur Rose Group 202007 CFO) | Chief Financial Officer (CFO) | Zur Rose Group (Group) | Switzerland |
| Cansier, Alexander (PANATecs 201003 Head Quality Assurance) | n. a. | Zukunftsfonds Heilbronn (Group) | Germany |
| Finkbeiner, Petra (PANATecs 201003) | Sales Manager / Marketing Manager | Zukunftsfonds Heilbronn (Group) | Germany |
| Flad, Thomas (PANATecs 201104 Head Technical Sales before 200512 Managing Director) | Sales Manager / Marketing Manager | Zukunftsfonds Heilbronn (Group) | Germany |
| Merz, Benedikt (PANATecs –201105c Managing Director) | Managing Director | Zukunftsfonds Heilbronn (Group) | Germany |
| Schwarz, Gerold (Biotecon 201701– Product Manager before Analytik Jena + Bruker Datlonics + PANATecs) | Product Manager (personnel) | Zukunftsfonds Heilbronn (Group) | Germany |
| Steffen, Günter (ZFHN Zukunfsfonds Heilbronn + 4/10 existent Chair Advisory Board of PANATecs) | Investment Manager | Zukunftsfonds Heilbronn (Group) | Germany |
| Villinger, Thomas R. (Tom) (ZFHN Zukunftsfonds Heilbronn 201910 CEO) | Chief Executive Officer (CEO) | Zukunftsfonds Heilbronn (Group) | Germany |
| Willinger, Thomas R. (ZFHN Zukunftsfonds Heilbronn 201105 Managing Director) | Managing Director | Zukunftsfonds Heilbronn (Group) | Germany |
| Schnappauf, Georg (ZSP Patentanwälte 201704 Partner) | Patent Attorney | ZSP Patentanwälte (Zwicker Schnappauf & Partner Patentanwälte PartG mbB) | Germany |
| Zwicker, Jörk (ZSP Patentanwälte 201704 Partner beore Boehmert & Boehmert) | Patent Attorney | ZSP Patentanwälte (Zwicker Schnappauf & Partner Patentanwälte PartG mbB) | Germany |
| Ekroos, Kim (Zor Biosciences 201003 Head of Bioanalytics) | Researcher (industry) | Zora Biosciences Oy | Finland |
| Kring, Ole (Scandinavian Micro Biodevices 200603 CEO) | Chief Executive Officer (CEO) | Zoetis (Group) | Denmark |
| Polzer, Robert (Zoetis 202307 EVP + President RnD) | Research & Development Manager | Zoetis (Group) | United States (USA) |
| Siegal, Gregg (ZoBio 201412 CEO) | Chief Executive Officer (CEO) | ZoBio B.V. | Netherlands |
| Destecroix, Harry S. (Ziylo 201711 Managing Director + Unit DX 201711 Managing Director + Co-Founder) | Managing Director | Ziylo Ltd. | United Kingdom (GB) |
| Cavdar, Avni (Zivak Technologies 201310 President) | President/Director/Head Business Group/Unit/Division | Zivak Technologies (TR) | Turkey |
| Cardon, Chris (Ziphius Vaccine 202105 CEO + Founder) | Chief Executive Officer (CEO) | Ziphius Vaccines N.V. | Belgium |
| Ghadanfar, Mathieu (Ziphius Vaacines 202106 Business Development Officer + CMO) | Business Development Manager / Strategy Manager | Ziphius Vaccines N.V. | Belgium |
| Thys, Hendrik (Ziphius Vaccines 202105 IR Manager formerly Consilium Strategic Communications 201602) | Public Relations Manager / Investor Relations Manager | Ziphius Vaccines N.V. | Belgium |
| Cheng, Ziqiang (Zack) (Zion Pharma 202305 CEO + Co-Founder) | Chief Executive Officer (CEO) | Zion Pharma Ltd. (CN) | China |
| French, J. Michael (Zion Pharma 202305 SVP CorpDev before MDRNA + Marina Biotech + Sirna Tx + Entelos +Bayer) | Business Development Manager / Strategy Manager | Zion Pharma Ltd. (CN) | China |
| Zhou, Ding (Zion Pharma 202305 CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Zion Pharma Ltd. (CN) | China |
| Ayni, Zyon (Zion Medical 201901 CEO) | Chief Executive Officer (CEO) | Zion Medical (IL) | Israel |
| Naftali, Esmira (Zion Medical 201901 Chief Operation + Development Officer) | Chief Operating Officer (COO) | Zion Medical (IL) | Israel |
| Rüger, Simon (ZIM Plant Technology GmbH 201204 Managing Director) | Managing Director | ZIM Plant Technology GmbH | Germany |
| Vernon, N. Geoffrey | n. a. | Ziggus Holding Ltd. | United Kingdom (GB) |
| Bailey, Mark (Zetta Genomics 202401– Board Advisor before CEO since 9/22) | Chief Executive Officer (CEO) | Zetta Genomics (Group) | United Kingdom (GB) |
| Burrows, Bryony (Zetta Genomics 202304 CFO) | Chief Financial Officer (CFO) | Zetta Genomics (Group) | United Kingdom (GB) |
| Medina Castello, Ignacio (Nacho) (Zetta Genomics 202402 CEO + Founder before CTO + CEO) | Chief Executive Officer (CEO) | Zetta Genomics (Group) | United Kingdom (GB) |
| Sommerford, Nathan (Zetta Genomics 202307– Chief Revenue Officer formerlay at Iqvia + Roche Diagnostics) | Sales Manager / Marketing Manager | Zetta Genomics (Group) | United Kingdom (GB) |
| Spooner, William H. (Will) (Zetta Genomics 202005– CEO + Co-Founder formerly Eagle Genomics) | Chief Executive Officer (CEO) | Zetta Genomics (Group) | United Kingdom (GB) |
| de Lange, Lex (Zernike 201008) | Chief Executive Officer (CEO) | Zernike (Group) | Netherlands |
| Berg, Niclas (Zeria 202307 Lead Corporate Communications at Tillotts Pharma) | Public Relations Manager / Investor Relations Manager | Zeria (Group) | Switzerland |
| Spleiss, Johannes (Zeria 202307 Head Scientific Affairs Tillotts Pharma + 202307– CEO of Mage Biologics) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Zeria (Group) | Switzerland |
| Tóth von Kiskér, Thomas A. (Zeria 202005 CEO of Tillotts Pharma AG) | Chief Executive Officer (CEO) | Zeria (Group) | Switzerland |
| Schleper, Christa (ZEB 200110 Head) | n. a. | Zentrum für molekulare Evolution und Biodiversität (ZEB) | Germany |
| Smith, Mike (Zenith Technologies 201608 US Sales Manager) | Sales Manager / Marketing Manager | Zenith Technologies (Group) | United States (USA) |
| Hassan, Namir (Zelluna 201912– CEO joined 2018 as CSO before Immunocore + GSK + Ludwig Institute for Cancer Research) | Chief Executive Officer (CEO) | Zelluna Immunotherapy AS | Norway |
| Robinson, Hans Ivar (Zelluna 201911 Board Chairman) | Board member, non-executive | Zelluna Immunotherapy AS | Norway |
| Klaue, Daniel (Zellmechanik Dresden 202011 Managing Director) | Managing Director | Zellmechanik Dresden GmbH | Germany |
| Schulte, Gerrit (Zeiss 202303 Head of Zeiss Ventures) | Investment Manager | Zeiss Ventures | Germany |
| Sebregts, Johan (ZIF 201410 Managing Director) | Managing Director | Zeeuws InvesteringsFonds (ZIF) | Netherlands |
| Hils, Martin (Zedira 201106 CEO + co-founder before N-Zyme Biotec) | Managing Director | Zedira GmbH | Germany |
| Pasternack, Ralf (Zedira 201106 Managing Director + co-founder before N-Zyme Biotec 200506 Managing Director) | Managing Director | Zedira GmbH | Germany |
| Calzolari, Simone (ZeClinics 202102 CEO + Co-Founder) | Chief Executive Officer (CEO) | ZeClinics (ES) | Spain (España) |
| Benjamin, Elad (Zebra Medical Vision 2014– CEO + Co-Founder before Carestream Healthcare Information Solutions) | Chief Executive Officer (CEO) | Zebra Medical Vision Ltd. (Zebra-Med) | Israel |
| Coull, Jeffrey (Encycle Therapeutics 201910 CEO) | Chief Executive Officer (CEO) | Zealand Pharma (Group) | Canada |
| Dulac, Emmanuel (Zealand Pharma 201909–202203 CEO LEFT 3/22) | Chief Executive Officer (CEO) | Zealand Pharma (Group) | Denmark |
| Hyttel, John (Zealand Pharma 1998–200301 COO + Co-founder RETIRED 1/13) | Chief Operating Officer (COO) | Zealand Pharma (Group) | Denmark |
| Leth Hillman, Hanne (Zealand Pharma 201508 SVP Investor Relations + Communications) | Public Relations Manager / Investor Relations Manager | Zealand Pharma (Group) | Denmark |
| Meelby Jensen, Britt (Zealand Pharma 201508 CEO) | Chief Executive Officer (CEO) | Zealand Pharma (Group) | Denmark |
| Steensberg, Adam (Zealand Pharma 202203 promoted to CEO before SVP Development + CMO) | Chief Medical Officer (CMO) | Zealand Pharma (Group) | Denmark |
| Steiness, Eva (Zealand Pharma 200502 CEO) | Chief Executive Officer (CEO) | Zealand Pharma (Group) | Denmark |
| Svedberg, Agneta (Zealand Pharma 201302– COO before Cantargia + Genmab + Oxigene Europe + Pharmacia & Upjohn AB) | Chief Operating Officer (COO) | Zealand Pharma (Group) | Denmark |
| Pillai, Girinath (Zastra Innovations Pvt Ltd 201701 CEO) | Chief Executive Officer (CEO) | Zastra Innovations Pvt. Ltd. | India |
| Castorina, Maurizio (Zambon 201511 CEO) | Chief Executive Officer (CEO) | Zambon (Group) | Italy |
| Gaiotto, Michele (Zambon 202211 CEO of HTH VC) | Chief Executive Officer (CEO) | Zambon (Group) | |
| Henig, Noreen Roth (201807– CMO before ProQR Therapeutics + Gilead Sciences) | Chief Medical Officer (CMO) | Zambon (Group) | Germany |
| Keywood, Charlotte (Zambon 201603 Head RnD before Addex Pharma CMO) | Research & Development Manager | Zambon (Group) | Italy |
| Shadday, Peter (Breath Therapeutics 201810– CCO before Vertex + Lundbeck + Gilead + Novartis) | Chief Commercial Officer (CCO) | Zambon (Group) | Netherlands |
| Stegemann, Jens (Breath Therapeutics 201609– CEO) | Managing Director | Zambon (Group) | Germany |
| Tascione, Roberto (Zambon 201907 CEO) | Chief Executive Officer (CEO) | Zambon (Group) | Italy |
| Zambon, Elena (Zambon 201907 President) | Board member | Zambon (Group) | Italy |
| Gaarmann, Michael (Albihns 200906 CEO) | Chief Executive Officer (CEO) | Zacco (Group) | Sweden |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
